JPM: Join us online or in San Francisco January 11-12
No images? Click here
The top of biopharma is up for grabs
January 11-12, 2027 | 7:00 am - 5:00 pm PT
Marriott Marquis, San Francisco + livestream
The pharma order that held for decades is starting to crack.
Blockbuster franchises are heading off patent with too little in the pipeline to replace them. A handful of biotechs that once looked like acquisition targets are now big enough to do the buying.
China has gone from fast follower to the source of molecules Western pharma is paying billions to license, and well-funded AI startups are going after work that used to belong to in-house R&D.
Some of today's giants won't hold their position through the end of the decade. What's next on the horizon?
Save with Early Bird for a limited time only. Virtual passes are free.
Endpoints journalists put the industry’s biggest questions directly to the executives, investors and dealmakers reshaping it. Hear what they see coming for biopharma in 2027 and beyond.
Join us for discussions that deliver real talk when the industry needs it most, while the Endpoints Hub offers a premium coworking lounge. This is your retreat from the intensity of Union Square — catch up on work or simply recharge between sessions.
EARLY BIRD SPECIAL RATES:
Get your in-person all-access pass now and save $200
Bring your team: Buy three all-access passes and save $900
Save with Early Bird for a limited time only. Virtual passes are free.
THE ENDPOINTS HUB: Your calm space in the middle of the JPM frenzy
Space to recharge
your devices and yourself
Breakfast and lunch each day, plus all-day snacks
Room to connect
with peers between sessions
Join us. Early Bird pricing is open for a limited time only.
Save $200 on an all-access pass or $900 when you bring a team of three.
Virtual passes are free.
EVENT SPONSORS
COMMUNITY PARTNERS
